WO2003066842A3 - Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen - Google Patents
Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen Download PDFInfo
- Publication number
- WO2003066842A3 WO2003066842A3 PCT/DE2003/000341 DE0300341W WO03066842A3 WO 2003066842 A3 WO2003066842 A3 WO 2003066842A3 DE 0300341 W DE0300341 W DE 0300341W WO 03066842 A3 WO03066842 A3 WO 03066842A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plasminogen
- nucleic acid
- organisms
- micro
- signal peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003566193A JP2005525798A (ja) | 2002-02-06 | 2003-02-06 | 微生物内での組み換えタンパク質の生産方法 |
AU2003210137A AU2003210137A1 (en) | 2002-02-06 | 2003-02-06 | Method for producing recombinant proteins in micro-organisms |
EP20030737248 EP1472346A2 (de) | 2002-02-06 | 2003-02-06 | Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen |
MXPA04007585A MXPA04007585A (es) | 2002-02-06 | 2003-02-06 | Metodo para la produccion de proteinas recombinantes en microorganismos. |
US10/503,910 US20050124036A1 (en) | 2002-02-06 | 2003-02-06 | Method for producing recombinant proteins in micro-organisms |
DE2003190418 DE10390418D2 (de) | 2002-02-06 | 2003-02-06 | Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen |
CA002475277A CA2475277A1 (en) | 2002-02-06 | 2003-02-06 | Method for producing recombinant proteins in micro-organisms |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02002716.5 | 2002-02-06 | ||
EP02002716 | 2002-02-06 | ||
US35780902P | 2002-02-21 | 2002-02-21 | |
US60/357,809 | 2002-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003066842A2 WO2003066842A2 (de) | 2003-08-14 |
WO2003066842A3 true WO2003066842A3 (de) | 2004-06-10 |
Family
ID=36743321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2003/000341 WO2003066842A2 (de) | 2002-02-06 | 2003-02-06 | Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1472346A2 (de) |
JP (1) | JP2005525798A (de) |
CN (1) | CN1768138A (de) |
AU (1) | AU2003210137A1 (de) |
CA (1) | CA2475277A1 (de) |
MX (1) | MXPA04007585A (de) |
WO (1) | WO2003066842A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101563100B (zh) * | 2006-08-28 | 2013-08-07 | 李季男 | 用于预防和治疗牙周病、改善牙周创伤愈合以及促进口腔健康的新药物靶标 |
EP2056865B1 (de) | 2006-08-28 | 2013-12-25 | Omnio Healer AB | Neues arzneimitteltarget zur verhinderung und behandlung von parodontalerkrankungen, verbesserung der heilung von parodontalwunden und förderung der mundgesundheit |
CN102482338B (zh) | 2009-07-10 | 2016-09-28 | 斯路姆基因公司 | 纤溶酶原和纤溶酶的变体 |
EP2494030A4 (de) * | 2009-10-30 | 2013-03-27 | Merck Sharp & Dohme | Verfahren zur herstellung therapeutischer proteine in pichia pastoris ohne dipeptidyl-aminopeptidase-aktivität |
KR20140015289A (ko) | 2011-01-05 | 2014-02-06 | 쓰롬보제닉스 엔.브이. | 플라스미노겐 및 플라스민 변이체 |
CN103764163A (zh) | 2011-08-12 | 2014-04-30 | 斯路姆基因公司 | 纤溶酶原和纤溶酶变体 |
DK3395354T3 (da) | 2015-12-18 | 2024-06-03 | Talengen Int Ltd | Plasminogen til anvendelse i behandling af diabetisk nefropati |
US11400142B2 (en) | 2015-12-18 | 2022-08-02 | Talengen International Limited | Treatment of diabetic nerve injury comprising administering plasminogen |
CN106890320A (zh) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | 一种用于预防或治疗急性及慢性血栓的方法 |
DK3391902T3 (da) | 2015-12-18 | 2023-11-20 | Talengen Int Ltd | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati |
EP3395359B1 (de) * | 2015-12-18 | 2023-11-01 | Talengen International Limited | Plasminogen zur verhinderung oder behandlung von akuter und chronischer thrombose |
US20190151421A1 (en) * | 2015-12-18 | 2019-05-23 | Talengen International Limited | Method for preventing or treating liver tissue damage and associated diseases |
CN106890323A (zh) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗肝组织损伤及其相关病症的方法 |
US10874721B2 (en) | 2015-12-18 | 2020-12-29 | Talengen International Limited | Method for preventing and treating cervical erosion |
CN108463236A (zh) | 2015-12-18 | 2018-08-28 | 泰伦基国际有限公司 | 一种预防或治疗放射性和化学性损伤的方法 |
CN106890319A (zh) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | 一种预防或治疗糖尿病性视网膜病变的方法 |
CA3008691A1 (en) * | 2015-12-18 | 2017-06-22 | Talengen International Limited | Method for preventing or treating diabetic retinopathy |
CN110114079A (zh) | 2016-12-15 | 2019-08-09 | 泰伦基国际有限公司 | 一种预防和治疗肥胖症的方法和药物 |
EP3556384B1 (de) | 2016-12-15 | 2024-04-10 | Talengen International Limited | Plasminogen zur behandlung von diabetes |
WO2018107687A1 (zh) | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗高脂血症的方法 |
CN108210902A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 预防和治疗脂肪肝的药物及其用途 |
CN108210911A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 一种促进胰岛素分泌的方法 |
CA3047175A1 (en) * | 2016-12-15 | 2018-06-21 | Talengen International Limited | Method for mitigating heart disease |
CN108210915A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 改善心脏病变的药物及其用途 |
JP7313058B2 (ja) | 2016-12-15 | 2023-07-24 | タレンゲン インターナショナル リミテッド | 組織器官の繊維化を予防及び治療するための方法 |
CN110366427A (zh) * | 2016-12-15 | 2019-10-22 | 泰伦基国际有限公司 | 一种预防和治疗病理性肾组织损伤的方法 |
CN111344004A (zh) | 2017-06-19 | 2020-06-26 | 泰伦基国际有限公司 | 一种调控glp-1/glp-1r 的方法和药物 |
CN109971736B (zh) * | 2017-12-27 | 2021-07-23 | 中科院大连化物所盘锦产业技术研究院有限公司 | 与草莓软化相关的氨基己糖苷酶及编码基因、制备与应用 |
CN110358780A (zh) * | 2018-04-10 | 2019-10-22 | 东莞泛亚太生物科技有限公司 | 一种编码β-甘露聚糖酶的基因,以及含该基因的重组质粒和重组菌及其构建方法 |
CN109456989B (zh) * | 2018-10-31 | 2022-03-29 | 陕西慧康生物科技有限责任公司 | 一种提高毕赤酵母分泌表达的载体的构建方法 |
CN116854792A (zh) * | 2023-04-28 | 2023-10-10 | 优睿赛思(武汉)生物科技有限公司 | 突变型α-factor信号肽及其编码基因、表达载体和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190756A (en) * | 1989-12-01 | 1993-03-02 | Genentech, Inc. | Methods and materials for expression of human plasminogen variant |
WO1994010318A1 (en) * | 1992-10-29 | 1994-05-11 | British Biotech Pharmaceuticals Limited | Thrombin activatable plasminogen derivatives |
WO2002050290A1 (en) * | 2000-12-21 | 2002-06-27 | Thromb-X Nv | A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
-
2003
- 2003-02-06 CN CNA038033267A patent/CN1768138A/zh active Pending
- 2003-02-06 JP JP2003566193A patent/JP2005525798A/ja active Pending
- 2003-02-06 AU AU2003210137A patent/AU2003210137A1/en not_active Abandoned
- 2003-02-06 WO PCT/DE2003/000341 patent/WO2003066842A2/de active Application Filing
- 2003-02-06 MX MXPA04007585A patent/MXPA04007585A/es unknown
- 2003-02-06 CA CA002475277A patent/CA2475277A1/en not_active Abandoned
- 2003-02-06 EP EP20030737248 patent/EP1472346A2/de not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190756A (en) * | 1989-12-01 | 1993-03-02 | Genentech, Inc. | Methods and materials for expression of human plasminogen variant |
WO1994010318A1 (en) * | 1992-10-29 | 1994-05-11 | British Biotech Pharmaceuticals Limited | Thrombin activatable plasminogen derivatives |
WO2002050290A1 (en) * | 2000-12-21 | 2002-06-27 | Thromb-X Nv | A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
Non-Patent Citations (5)
Title |
---|
CREGG J M ET AL: "RECOMBINANT PROTEIN EXPRESSION IN PICHIA PASTORIS", MOLECULAR BIOTECHNOLOGY, TOTOWA, NJ, US, vol. 16, no. 1, September 2000 (2000-09-01), pages 23 - 52, XP001078868, ISSN: 1073-6085 * |
DUMAN J G ET AL: "O-MANNOSYLATION OF PICHIA PASTORIS CELLULAR AND RECOMBINANT PROTEINS", BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, ACADEMIC PRESS, US, vol. 28, no. 1, August 1998 (1998-08-01), pages 39 - 45, XP001070866, ISSN: 0885-4513 * |
ROY N ET AL: "Expression of Human Gelatinase B in Pichia pastoris", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 16, no. 2, July 1999 (1999-07-01), pages 324 - 330, XP004441668, ISSN: 1046-5928 * |
SREEKRISHNA K ET AL: "Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 190, no. 1, 29 April 1997 (1997-04-29), pages 55 - 62, XP004064384, ISSN: 0378-1119 * |
WANG J ET AL: "STRUCTURE AND FUNCTION OF MICROPLASMINOGEN: I. METHIONINE SHUFFLING, CHEMICAL PROTEOLYSIS, AND PROENZYME ACTIVATION", PROTEIN SCIENCE, CAMBRIDGE UNIVERSITY PRESS, CAMBRIDGE, GB, vol. 4, no. 9, September 1995 (1995-09-01), pages 1758 - 1767, XP001070157, ISSN: 0961-8368 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003066842A2 (de) | 2003-08-14 |
AU2003210137A8 (en) | 2003-09-02 |
MXPA04007585A (es) | 2005-09-20 |
CN1768138A (zh) | 2006-05-03 |
AU2003210137A1 (en) | 2003-09-02 |
CA2475277A1 (en) | 2003-08-14 |
EP1472346A2 (de) | 2004-11-03 |
JP2005525798A (ja) | 2005-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003066842A3 (de) | Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen | |
WO2005019251A3 (en) | Novel fungal proteins and nucleic acids encoding same | |
HUP0303246A2 (hu) | Aktív fehérjék fokozott kinyerése | |
EP0837131A3 (de) | Zusammensetzungen mit Staphylococcus Fibronektinbindungsprotein | |
IL139478A0 (en) | Hybrid protein | |
IL131986A0 (en) | Shuffling of heterologous dna sequences | |
WO2002031134A3 (en) | Novel serine protease genes related to dppiv | |
WO2007036299A3 (de) | Verfahren zur amidierung von polypeptiden mit c-terminalen basischen aminosäuren unter verwendung spezifischer endoproteasen | |
WO2003035861A3 (en) | Thrombin-cleavable chimeric proteins | |
BR0312521A (pt) | Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado | |
WO2003004628A3 (de) | Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms | |
WO2005032581A3 (en) | Hybrid molecules having factor vii/viia activity | |
WO2003008449A8 (en) | Ntb-a, a surface molecule involved in natural killer cells activity | |
ATE510911T1 (de) | Prothrombin aktivierendes protein | |
WO2002034915A3 (en) | Preferred segments of neural thread protein and methods of using the same | |
WO2002090500A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
AU2003902414A0 (en) | Flowering induction | |
ZA200007619B (en) | New peptide fragments for protein purification. | |
WO1999031256A3 (en) | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis | |
WO2004065554A3 (en) | Human saa3 nucleic acid molecule, protein, and methods of use for same | |
WO2003073980A3 (en) | Recombinant protein c variants | |
WO2004053117A3 (en) | Serine protease | |
WO2003022883A3 (de) | Verwendung eines proteins zur herstellung eines medikaments zur stimulierung des angeborenen unspezifischen immunsystems | |
BRPI0214903A2 (pt) | ácido nucléico isolado codificador de uma molécula precursora de trombina bovina recombinante, polinucleotídeo codificador de um polipeptídeo, molécula precursora, vetor, célula hospedeira, processo para a purificação de trombina ativada, e, método de produção de uma proteína ativada | |
WO2000050612A3 (en) | Recombinant protein c activator and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003737248 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 423/MUMNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2475277 Country of ref document: CA Ref document number: 20038033267 Country of ref document: CN Ref document number: 2003566193 Country of ref document: JP Ref document number: PA/a/2004/007585 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2003737248 Country of ref document: EP |
|
REF | Corresponds to |
Ref document number: 10390418 Country of ref document: DE Date of ref document: 20050113 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10390418 Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10503910 Country of ref document: US |